{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:21:50Z","timestamp":1764944510309,"version":"3.46.0"},"reference-count":43,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Geriatrics"],"abstract":"<jats:p>Background: Parkinson\u2019s disease (PD) is a prevalent neurodegenerative disorder among the elderly, with its incidence increasing as the population ages. Despite the predominance of patients with PD aged 75 years and older in clinical settings, limited research has focused on their rehabilitation. This study aimed to compare the clinical characteristics and rehabilitation outcomes of elderly patients aged 75 years and older. Methods: A retrospective analysis was conducted on 141 patients with PD aged 65 years and older who underwent intensive inpatient rehabilitation. Patients were categorized into two subgroups: the young-old group (65\u201374 years, n = 58) and the old-old group (\u226575 years, n = 83). The rehabilitation program included daily 2 h sessions, 6 days a week, combining physical, occupational, and speech\u2013language\u2013hearing therapies to enhance functional impairments and activities of daily living (ADL). Clinical characteristics and rehabilitation outcomes were compared between these groups. Results: The old-old group exhibited significantly higher rates of sarcopenia, higher Unified Parkinson\u2019s Disease Rating Scale (UPDRS) scores, poorer balance scores and cognitive function, and lower ADL scores compared with the young-old group. However, both groups demonstrated significant improvements in UPDRS, Berg Balance Scale, 10 m walk test, and Functional Independence Measure scores, indicating enhanced motor function and ADL. Conclusions: Our retrospective study suggests that inpatient rehabilitation is associated with improvement in parkinsonism, motor symptoms, and ADL in patients with PD aged 75 years or older, highlighting the potential benefits of intensive rehabilitation even in advanced age. These findings underscore the need for prospective studies to confirm these effects. Trial registration: UMIN000056042 (last amendment 5 November 2024, retrospectively registered).<\/jats:p>","DOI":"10.3390\/geriatrics10060163","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:17:07Z","timestamp":1764940627000},"page":"163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Clinical Characteristics and Rehabilitation Outcomes in Elderly Patients with Parkinson\u2019s Disease: A Retrospective Study"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4865-7266","authenticated-orcid":false,"given":"Toshiya","family":"Shimamoto","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, Kumamoto Southern Regional Hospital, Kumamoto 861-4214, Japan"},{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Misumi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhisa","family":"Uchino","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kumamoto Southern Regional Hospital, Kumamoto 861-4214, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kumamoto Southern Regional Hospital, Kumamoto 861-4214, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Motoshima","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Kumamoto Southern Regional Hospital, Kumamoto 861-4214, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Uchino","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kumamoto Southern Regional Hospital, Kumamoto 861-4214, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6814-0582","authenticated-orcid":false,"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13311-013-0239-9","article-title":"Treatment of Parkinson\u2019s disease: What\u2019s in the non-dopaminergic pipeline?","volume":"11","author":"Hung","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson\u2019s disease: A review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mdc3.12568","article-title":"Epidemiology of Parkinson\u2019s Disease-East Versus West","volume":"5","author":"Abbas","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_6","unstructured":"Statistics and Information Department, Minister\u2019s Secretariat, Ministry of Health, Labour and Welfare (2023). Vital Statistics 2000, Ministry of Health, Labor and Welfare."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14802\/jmd.18064","article-title":"Heterogeneous Patterns of Striatal Dopamine Loss in Patients with Young- versus Old-Onset Parkinson\u2019s Disease: Impact on Clinical Features","volume":"12","author":"Chung","year":"2019","journal-title":"J. Mov. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/cjn.2015.244","article-title":"Early-onset vs. Late-onset Parkinson\u2019s disease: A Clinical-pathological Study","volume":"43","author":"Ferguson","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","article-title":"Variable expression of Parkinson\u2019s disease: A base-line analysis of the DATATOP cohort. The Parkinson Study Group","volume":"40","author":"Jankovic","year":"1990","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-017-1711-1","article-title":"Motor and non-motor symptoms in old-age onset Parkinson\u2019s disease patients","volume":"124","author":"Mendonca","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.01.009","article-title":"Octogenarian parkinsonism\u2014Clinicopathological observations","volume":"37","author":"Rajput","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/BPL-150021","article-title":"The Effects of Exercise on Dopamine Neurotransmission in Parkinson\u2019s Disease: Targeting Neuroplasticity to Modulate Basal Ganglia Circuitry","volume":"1","author":"Petzinger","year":"2015","journal-title":"Brain Plast."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/1545968320952799","article-title":"Physiotherapy in Parkinson\u2019s Disease: A Meta-Analysis of Present Treatment Modalities","volume":"34","author":"Radder","year":"2020","journal-title":"Neurorehabil. Neural Repair."},{"key":"ref_14","first-page":"CD013856","article-title":"Physical exercise for people with Parkinson\u2019s disease: A systematic review and network meta-analysis","volume":"1","author":"Ernst","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/ggi.13118","article-title":"Redefining the elderly as aged 75 years and older: Proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society","volume":"17","author":"Ouchi","year":"2017","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease (2003). The Unified Parkinson\u2019s Disease Rating Scale (UPDRS): Status and recommendations. Mov. Disord., 18, 738\u2013750.","DOI":"10.1002\/mds.10473"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.apmr.2004.11.005","article-title":"Validating the Berg Balance Scale for patients with Parkinson\u2019s disease: A key to rehabilitation evaluation","volume":"86","author":"Qutubuddin","year":"2005","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00415-018-8921-9","article-title":"The clinical significance of 10-m walk test standardizations in Parkinson\u2019s disease","volume":"265","author":"Lindholm","year":"2018","journal-title":"J. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mds.22017","article-title":"The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson\u2019s disease","volume":"23","author":"Gill","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0003-9993(93)90119-U","article-title":"A validation of the functional independence measurement and its performance among rehabilitation inpatients","volume":"74","author":"Dodds","year":"1993","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archneurol.2009.295","article-title":"The clinically important difference on the unified Parkinson\u2019s disease rating scale","volume":"67","author":"Shulman","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/NPT.0000000000000055","article-title":"Defining the clinically meaningful difference in gait speed in persons with Parkinson disease","volume":"38","author":"Hass","year":"2014","journal-title":"J. Neurol. Phys. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mds.20914","article-title":"Minimal clinically important change on the unified Parkinson\u2019s disease rating scale","volume":"21","author":"Schrag","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2522\/ptj.20070214","article-title":"Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism","volume":"88","author":"Steffen","year":"2008","journal-title":"Phys. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ctim.2018.12.008","article-title":"The effect of functional-task training on activities of daily living for people with Parkinson;s disease, a systematic review with meta-analysis","volume":"42","author":"Perry","year":"2019","journal-title":"Complement. Ther. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cusso, M.E., Donald, K.J., and Khoo, T.K. (2016). The Impact of Physical Activity on Non-Motor Symptoms in Parkinson\u2019s Disease: A Systematic Review. Front. Med., 3.","DOI":"10.3389\/fmed.2016.00035"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0269215520918631","article-title":"Effects of a core stabilization training program on balance ability in persons with Parkinson\u2019s disease: A randomized controlled trial","volume":"34","author":"Valenza","year":"2020","journal-title":"Clin. Rehabil."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0003-9993(03)00046-7","article-title":"The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson\u2019s disease","volume":"84","author":"Hirsch","year":"2003","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Schlenstedt, C., Paschen, S., Kruse, A., Raethjen, J., Weisser, B., and Deuschl, G. (2015). Resistance versus Balance Training to Improve Postural Control in Parkinson\u2019s Disease: A Randomized Rater Blinded Controlled Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140584"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/XEB.0000000000000018","article-title":"Sarcopenia in older people","volume":"12","author":"Yu","year":"2014","journal-title":"Int. J. Evid. Based Healthc."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Cai, Y., Feng, F., Wei, Q., Jiang, Z., Ou, R., and Shang, H. (2021). Sarcopenia in Patients With Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.598035"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lima, D.P., de Almeida, S.B., Bonfadini, J.C., de Luna, J.R.G., de Alencar, M.S., Pinheiro-Neto, E.B., Viana-Junior, A.B., Veras, S.R.O., Sobreira-Neto, M.A., and Roriz-Filho, J.S. (2020). Clinical correlates of sarcopenia and falls in Parkinson\u2019s disease. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227238"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000492572","article-title":"Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson\u2019s Disease: A Cross-Sectional Study","volume":"65","author":"Peball","year":"2019","journal-title":"Gerontology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/1028415X.2023.2190246","article-title":"Sarcopenia and dynapenia is correlated to worse quality of life perception in middle-aged and older adults with Parkinson\u2019s disease","volume":"27","author":"Medeiros","year":"2024","journal-title":"Nutr. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson\u2019s disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Mov. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000341998","article-title":"Cognitive impairment in Parkinson\u2019s disease: The dual syndrome hypothesis","volume":"11","author":"Kehagia","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105908","DOI":"10.1016\/j.parkreldis.2023.105908","article-title":"Effects of physical exercise interventions on cognitive function in Parkinson\u2019s disease: An updated systematic review and meta-analysis of randomized controlled trials","volume":"117","author":"Kim","year":"2023","journal-title":"Park. Relat. Disord."},{"key":"ref_39","first-page":"6233835","article-title":"Onset of Postural Instability in Parkinson\u2019s Disease Depends on Age rather than Disease Duration","volume":"2022","author":"Becker","year":"2022","journal-title":"Park. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","article-title":"Cognitive correlates of cortical cholinergic denervation in Parkinson\u2019s disease and parkinsonian dementia","volume":"253","author":"Bohnen","year":"2006","journal-title":"J. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/brain\/awad325","article-title":"Clinical severity in Parkinson\u2019s disease is determined by decline in cortical compensation","volume":"147","author":"Johansson","year":"2024","journal-title":"Brain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/mdc3.12956","article-title":"White Matter Hyperintensities Related to Parkinson\u2019s Disease Executive Function","volume":"7","author":"Linortner","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S1353-8020(09)70831-4","article-title":"The clinical progression of Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2009","journal-title":"Park. Relat. Disord."}],"container-title":["Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3417\/10\/6\/163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:17:48Z","timestamp":1764944268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3417\/10\/6\/163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["geriatrics10060163"],"URL":"https:\/\/doi.org\/10.3390\/geriatrics10060163","relation":{},"ISSN":["2308-3417"],"issn-type":[{"value":"2308-3417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}